An2 Therapeutics, Inc. Share Price: ANTX (An2 Therapeutics, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is An2 Therapeutics, Inc. share price today?

Accepted Answer

An2 Therapeutics, Inc. (ANTX) share price today is {{live_price}}.

Question 2

Can Indians buy An2 Therapeutics, Inc. shares?

Accepted Answer

Yes, Indians can invest in the An2 Therapeutics, Inc. (ANTX) from India.

With INDmoney, you can buy An2 Therapeutics, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy An2 Therapeutics, Inc. at zero transaction cost.

Question 3

How can I buy An2 Therapeutics, Inc. shares from India?

Accepted Answer

It is very easy to buy An2 Therapeutics, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of An2 Therapeutics, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of An2 Therapeutics, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in An2 Therapeutics, Inc. stocks?

Accepted Answer

To start investing in An2 Therapeutics, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of An2 Therapeutics, Inc.

Accepted Answer

Today’s highest price of An2 Therapeutics, Inc. (ANTX) is {{1_rba_end}}.

Today’s lowest price of An2 Therapeutics, Inc. (ANTX) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of An2 Therapeutics, Inc.

Accepted Answer

Today's market capitalisation of An2 Therapeutics, Inc. ANTX is 453.0M

Question 8

What is the 52 Week High and Low Range of An2 Therapeutics, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage An2 Therapeutics, Inc. is down from its 52 Week High?

Accepted Answer

An2 Therapeutics, Inc. (ANTX) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage An2 Therapeutics, Inc. is up from its 52 Week low?

Accepted Answer

An2 Therapeutics, Inc. (ANTX) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of An2 Therapeutics, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of An2 Therapeutics, Inc.

Accepted Answer

Mr. Joseph S. Zakrzewski is the current Chief Executive Officer (CEO) of An2 Therapeutics, Inc..

Period	An2 Therapeutics, Inc.	Index (Russel 2000)
3 Months	92.34%	0.0%
6 Months	62.26%	-1.9%
1 Year	-13.08%	6.3%
3 Years	4.42%	14.9%

Market Capitalization	453.0M
Book Value	$4.0
Dividend Share	0.0
Dividend Yield	0.0%
Earnings Per Share (EPS)	-3.49
Wall Street Target Price	24.0

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-32.48%
Return On Equity TTM	-53.34%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
Diluted Eps TTM	-3.49
Quarterly Earnings Growth YOY	0.0

An2 Therapeutics, Inc. (ANTX)

Insights on An2 Therapeutics, Inc.

Vs NVO

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Peers

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-3.36
EPS Estimate Next Year	-3.45
EPS Estimate Current Quarter	-0.85
EPS Estimate Next Quarter	-0.92

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
An2 Therapeutics, Inc.	7.92%	62.26%	-13.08%	4.42%	4.42%
Moderna, Inc.	-5.55%	-35.23%	-14.63%	50.11%	455.32%
Regeneron Pharmaceuticals, Inc.	0.01%	-0.39%	11.95%	45.71%	105.45%
Novo Nordisk A/s	-4.33%	13.96%	77.36%	164.9%	284.93%
Seagen, Inc.	2.4%	5.02%	54.07%	9.88%	161.08%
Vertex Pharmaceuticals Incorporated	-0.15%	9.93%	16.91%	33.34%	81.18%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
An2 Therapeutics, Inc.	NA	NA	NA	-3.36	-0.53	-0.32	0.0	4.0
Moderna, Inc.	34.94	34.94	0.0	-3.66	0.07	0.01	0.0	44.49
Regeneron Pharmaceuticals, Inc.	22.08	22.08	9.01	41.82	0.19	0.1	0.0	225.94
Novo Nordisk A/s	43.05	43.05	2.03	1.64	0.82	0.22	0.01	2.52
Seagen, Inc.	NA	NA	18.53	-3.52	-0.26	-0.13	0.0	13.96
Vertex Pharmaceuticals Incorporated	26.67	26.67	0.41	14.71	0.25	0.16	0.0	60.01

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
An2 Therapeutics, Inc.	Buy	$453.0M	4.42%	NA	0.0%
Moderna, Inc.	Buy	$38.2B	455.32%	34.94	11.33%
Regeneron Pharmaceuticals, Inc.	Buy	$90.6B	105.45%	22.08	33.93%
Novo Nordisk A/s	Buy	$412.6B	284.93%	43.05	33.4%
Seagen, Inc.	Hold	$39.8B	161.08%	NA	-33.55%
Vertex Pharmaceuticals Incorporated	Buy	$89.7B	81.18%	26.67	35.4%

Organization	An2 Therapeutics, Inc.
Employees	35
CEO	Mr. Joseph S. Zakrzewski
Industry	Services